MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

01 Aug 2025 Evaluate
A slight decline in the revenue of Rs. 246.68 millions was seen for the June 2025 quarter as against Rs. 247.80 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 34.50  millions from Rs. 46.52 millions ,decline by -25.84%.Operating profit for the quarter ended June 2025 decreased to 79.59 millions as compared to 86.69 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 246.68 247.80 -0.45 246.68 247.80 -0.45 1085.96 1258.95 -13.74
Other Income 6.62 5.45 21.47 6.62 5.45 21.47 37.30 30.71 21.46
PBIDT 79.59 86.69 -8.19 79.59 86.69 -8.19 429.42 448.77 -4.31
Interest 9.40 3.16 197.47 9.40 3.16 197.47 20.77 5.98 247.32
PBDT 70.19 83.53 -15.97 70.19 83.53 -15.97 408.65 442.79 -7.71
Depreciation 24.20 20.18 19.92 24.20 20.18 19.92 95.67 61.10 56.58
PBT 45.99 63.35 -27.40 45.99 63.35 -27.40 312.98 381.69 -18.00
TAX 11.49 16.83 -31.73 11.49 16.83 -31.73 81.99 100.52 -18.43
Deferred Tax 1.30 0.28 364.29 1.30 0.28 364.29 -0.45 6.74 -106.68
PAT 34.50 46.52 -25.84 34.50 46.52 -25.84 230.99 281.17 -17.85
Equity 128.38 128.38 0.00 128.38 128.38 0.00 128.38 125.83 2.03
PBIDTM(%) 32.26 34.98 -7.77 32.26 34.98 -7.77 39.54 35.65 10.93
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..